Treatment of idiopathic pulmonary fibrosis: a position paper from a Nordic expert group-Reference-Cited by-同舟云学术

Treatment of idiopathic pulmonary fibrosis: a position paper from a Nordic expert group

Published:2016-11-13 Issue:2 Volume:281 Page:149-166
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:J Intern Med

Author:

Sköld C. M.¹²,Bendstrup E.³,Myllärniemi M.⁴,Gudmundsson G.⁵,Sjåheim T.⁶,Hilberg O.³,Altraja A.⁷⁸,Kaarteenaho R.⁹¹⁰¹¹,Ferrara G.¹²

Affiliation:

1. Respiratory Medicine Unit; Center for Molecular Medicine; Department of Medicine; Solna Karolinska Institutet; Stockholm Sweden

2. Lung-Allergy Clinic Karolinska University Hospital Solna; Stockholm Sweden

3. Department of Respiratory Medicine and Allergy; Aarhus University Hospital; Aarhus Denmark

4. Transplantation laboratory and Heart and Lung Center; University of Helsinki and Helsinki University Hospital; Helsinki Finland

5. Department of Respiratory Medicine and Sleep; Faculty of Medicine; Landspitali University Hospital; University of Iceland; Reykjavik Iceland

6. Department of Respiratory Medicine; Oslo University Hospital; Rikshospitalet Oslo Norway

7. Department of Pulmonary Medicine; University of Tartu; Tartu Estonia

8. Lung Clinic; Tartu University Hospital; Tartu Estonia

9. Unit of Medicine and Clinical Research; Pulmonary Division; Division of Respiratory Medicine; University of Eastern Finland and Center of Medicine and Clinical Research; Kuopio Finland

10. Respiratory research; Research Unit of Internal Medicine; Medical Research Center; University of Oulu and Oulu University Hospital; Oulu Finland

11. Kuopio University Hospital; Kuopio Finland

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/joim.12571/fullpdf

Reference134 articles.

1. Incidence and prevalence of idiopathic pulmonary fibrosis;Raghu;Am J Respir Crit Care Med,2006

2. Idiopathic pulmonary fibrosis-a systematic review on methodology for the collection of epidemiological data;Kaunisto;BMC Pulm Med,2013

3. A cohort study of interstitial lung diseases in central Denmark;Hyldgaard;Respir Med,2014

4. An earlier and more confident diagnosis of idiopathic pulmonary fibrosis;Bois;Eur Respir Rev,2012

5. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001;American Thoracic Society;Am J Respir Crit Care Med,2002

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CYP1A2 Polymorphism and Drug Co-administration Affect the Blood Levels and Adverse Effects of Pirfenidone;Therapeutic Drug Monitoring;2024-05-01

2. Therapeutic Strategies for Idiopathic Pulmonary Fibrosis – Thriving Present and Promising Tomorrow;The Journal of Clinical Pharmacology;2024-02-12

3. Innovative Pre-Clinical Data Using Peptides to Intervene in the Evolution of Pulmonary Fibrosis;International Journal of Molecular Sciences;2023-07-04

4. Idiopathic pulmonary fibrosis and the role of genetics in the era of precision medicine;Frontiers in Medicine;2023-04-27

5. The Inhibitory Effect of Phycocyanin Peptide on Pulmonary Fibrosis In Vitro;Marine Drugs;2022-11-06